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Abstract
With many live imaging techniques, it is crucial that a deep level of anesthesia is reached and maintained
throughout image acquisition without reducing zebrafish viability. This is particularly true for three-dimensional
tomographic imaging modalities. Currently, the most commonly used anesthetic in the zebrafish community, MS-
222 (tricaine methanesulfonate), does not allow this. We show, using a combination of both MS-222 and
isoflurane, that we can significantly improve the anesthetic regime required for motionless image acquisition of
live adult zebrafish. We have benchmarked this against the requirements of our novel quantitative imaging
platform, compressive sensing optical projection tomography. Using nonpigmented transgenic zebrafish, we show
that a combination of 175ppm of both anesthetics improves the maintenance of deep anesthesia for prolonged
periods of time and it can be used repeatedly to enable longitudinal imaging. Importantly, it does not affect the
health or viability of the adult zebrafish. We also show that nonpigmented fish, with a mutated form of the gene
transparent, took significantly longer to reach deep anesthesia. The anesthetic regime presented in this study
should lead to significant improvements in accuracy and information achievable from imaging live adult zebrafish
and in its application to longitudinal studies.
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Introduction
Although much has been learned from in vitrostudies, the absence of integrative organ systems and
true cellular environments limits their relevance and utility
when studying disease and aiding drug development. In vivo
studies can overcome this. Performing live global imaging
of model organisms can provide spatial and temporal in-
formation of dynamic interactions at the molecular and
signaling level.1 Furthermore, it enables longitudinal stud-
ies that can provide greater accuracy when studying disease
and drug efficacy, while reducing the number of animals
required for research.
The use of zebrafish (Danio rerio) as a model organism
is increasing owing to numerous beneficial features, includ-
ing a rapid generation time, ease of genetic manipula-
tion, high-throughput capacity, and a fully sequenced,
conserved genome.2 In addition, the embryonic transpar-
ency and generation of nonpigmented mutant lines that
lack pigmentation, such as casper (mitfaw2/w2; roya9/a9)
and TraNac (mitfaw2/w2, mpvb18/b18), enable fluorescence
detection at all life stages when using optical imaging
techniques.3–6
We have recently developed compressive sensing optical
projection tomography (CS-OPT), a novel three-dimensional
(3D) imaging modality capable of longitudinal quantitative
analysis of tumor progression and vascular development in
live adult nonpigmented zebrafish.7 CS-OPT facilitates me-
soscopic fluorescence imaging of transparent samples with
low phototoxicity and quick acquisition times.
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For many longitudinal imaging techniques, it is important
that zebrafish reach a deep level of anesthesia, where they
have no response to external stimuli, for prolonged periods of
time without resulting in detrimental or lethal side effects
(Table 1).8,9 This is particularly true for CS-OPT, whereby
the 3D reconstruction algorithms are reliant upon motionless
specimens and any slight movement during acquisition in-
troduces errors in the reconstructed images and resulting
quantifications.5,10,11
The anesthetic regime widely used by the zebrafish com-
munity is 4.2% (168 ppm) MS-222 (tricaine methanesulfo-
nate), based upon its reliability and consistency compared to
other agents.12,13 However, with prolonged exposure, zeb-
rafish experience respiratory and cardiac failure leading to
higher mortality rates.14,15 It has been reported that a com-
bination of MS-222 with isoflurane reduces cardiac failure
and prolongs time under deep anesthesia before reaching
respiratory arrest and medullary collapse.16 Furthermore, the
recovery period when using the combined anesthesia is re-
duced when compared to MS-222 alone. However, neither
the repeated use of the combined regime nor the maintenance
of deep anesthesia was analyzed.
In this study, we report the use of a combined MS-222 and
isoflurane anesthetic regime for the immobilization and im-
aging of the transgenic (Tg) and mutant zebrafish line: TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12).7 This
zebrafish line, hereafter referred to as ‘‘TraNac transgenic,’’ is
nonpigmented and has a red fluorescent vasculature with an
inducible, eGFP-tagged oncogenic KRAS transgene. Upon
treatment with the inducer, doxycycline, eGFP-KRASV12 is
expressed specifically in hepatocytes leading to tumor pro-
gression, which is highly similar to hepatocellular carci-
noma.7 CS-OPT imaging of adult tumor-burdened fish
requires*3.5min to acquire signals for both the tumor and
vasculature. This translates to an average time of *10min,
when including specimen positioning on the CS-OPT system.
We have routinely observed that using MS-222 alone ‘‘Tra-
Nac transgenic’’ zebrafish take extended periods of time to
reach deep anesthesia in comparison to wild-type (AB)
zebrafish and, on occasion, are unable to maintain the lack of
response to external stimuli, a characteristic of deep anes-
thesia (Table 1). We report, in this study, an optimized re-
gime combining doses of MS-222 and isoflurane to enable
deep anesthesia that can be maintained for prolonged periods
of time. We show that this regime can be repeatedly applied
to adult zebrafish without having an impact on health or vi-
ability, highlighting its use for longitudinal studies. Fur-
thermore, nonpigmented zebrafish are seen to reach deep




Zebrafish lines were bred and maintained within the UCL
fish facility according to UCL protocols where all procedures
conformed to ASPA 1986. System water used had the fol-
lowing parameters: 0mg/L (undetectable trace) ammonia,
under 0.3mg/L nitrite, under 50mg/L nitrate, pH 7–8, con-
ductivity of *420 microSiemens, 27C–28C water tem-
perature, 6mg/L dissolved gases, and a gH of 4dGH. The
water runs through a recirculating system at a tank flow rate
of 6 water changes per hour with a 10% total water change
per 24 h. Fish were fed twice daily with both decapsulated
Instar I Artemia and 2 commercially available micro-
encapsulated diets containing a high crude protein of 40%–
50%, which comprised fish meal, soybean, cuttlefish, and
wheat in varying quantities. Sexually mature fish were kept
at a maximum of 5 per liter and all fish used were female
and between 6 and 9 months old.
Zebrafish strains
Wild-type (AB) zebrafish were held in a colony size of
*550 and generated from >40 individual pairwise crosses to
create the next generation. The strain has been kept at UCL in
excess of 16 years as a closed colony. Generation time is
between 6 and 9 months.
Casper (roy-/roy-; nacre-/nacre- double mutant) zebra-
fish were gifted by Leonard Zon (Harvard Medical School)
and held as a colony of 80, generated from multiple pairwise
crosses and occasional outcrossing to AB, followed by
backcrossing to maintain line viability. These have been kept
at UCL for *10 generations. Generation time is between 9
and 12 months.
TraNac (tra-/tra-; nacre-/nacre- double mutant) gifted by
Julian Lewis (Cancer Research Institute) were held at a col-
ony size of *100 as closed colony embryos taken from
multiple individual pairwise crosses to create the next gen-
eration. These fish have been kept at UCL for approxima-
tely four generations. Generation time is between 6 and 9
months.
The transgenic (Tg) line Tg (KDRmCherry:cmlc2GFP)
was gifted by Ian Zachary (UCL) and they have been held as a
colony of *30 fish for three generations. They were origi-
nally created at UCL and maintained as a sibling incross.
They have a wild-type background with mCherry and GFP-
labeled vasculature and cardiomyocytes, respectively.
TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRA
SV12) zebrafish were held as a colony of*30 fish for three
generations and maintained as a sibling incross. These were
Table 1. Definitions of the Levels of Anesthesia Experienced, with Corresponding
Physical Movement and Reaction to External Stimuli
Level Movement Opercula Reaction to stimuli
Light anesthesia Equilibrium loss Increase Only to substantial
Erratic swimming
Deep anesthesia None Decrease None
Medullary collapse (death) None Ceases None
Table adapted from McFarland (1959) and Ross and Ross (2008).
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created at UCL through crossing TraNac with both Tg (KDR:
mCherry) gifted by Steve Wilson (UCL) and Tg (Fabp10-
rtTA:TRE-eGFPKRASV12) gifted by Zhiyuan Gong (National
Univeristy of Singapore). These zebrafish are nonpigmented
with mCherry-labeled vasculature and have inducible ex-
pression of liver-specific eGFP-tagged KRASV12.
Anesthetic preparations
A stock solution of 4000 ppmMS-222 (Sigma) was created
at pH7 and stored at -20C, as described in The zebrafish
book.12 Isoflurane (Abbott) was dissolved in ethanol to create
a 100,000 ppm stock solution and stored at 4C. The desired
amounts of anesthetic were added to fish water immediately
before use.
Testing anesthesia
Zebrafish were placed into 100 mL of system water
containing the prescribed anesthesia concentrations. Deep
anesthesia was determined by the loss of righting reflex and
response to external stimuli, determined through both tapping
the bench and pinching the caudal fin, in line with Table 1.
Once this was achieved, the fish were placed into a fluori-
nated ethylene propylene (FEP) tube used for CS-OPT con-
taining the same anesthetic solution. While in the tube, the
fish were closely monitored for movement, response to ex-
ternal stimuli through tapping the bench, and opercula
movement. This external stimulus was chosen due to deep
anesthesia being the only stage that zebrafish lose their re-
sponse to vibration or strong pressure, where the latter would
be inappropriate to test within the FEP tubing. Furthermore,
tapping on the bench is a greater stimulus than what would
be experienced during CS-OPT acquisition. This is due to
image acquisition being performed upon an optical bench,
preventing vibration, and the rotational acceleration being
minimal so they are not moved during imaging.7 When
opercula movement ceased (before medullary collapse) or
the fish awoke they were removed from the tube and placed
in a recovery tank. Their recovery was monitored and a
Pasteur pipette was used to gently squirt oxygenated water
over the gills. One hundred percent of zebrafish recovered.
Recovery was defined as the ability for the fish to swim once
the righting reflex had returned.
Determining the time to reach deep anesthesia using
168 ppm MS-222 within different zebrafish strains
The strains used for testing MS-222 alone were wild type
(AB), Tg (KDRmCherry:cmlc2GFP), Casper, TraNac, and Tra-
Nac Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12).
For each strain, n=5 and the statistical tests used were as
described below.
Using a combination of MS-222 and isoflurane
to achieve and maintain deep anesthesia
Anesthetic doses trialed included 50/50 ppm (MS-222/
isoflurane), 60/60, 65/65, 85/85, 100/100, 150/150, 170/170,
175/0, 175/175, 175/200, and 175/250 ppm. TraNac Tg (KDR:
mCherry:Fabp10-rtTA:TRE-eGFPKRASV12) zebrafish were
used where n‡ 4 for each anesthetic dose.
Repeatedly using a combination of MS-222
and isoflurane to consistently achieve
and maintain deep anesthesia
Anesthesia was repeatedly tested once a week for 4 weeks
on TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRA
SV12) zebrafish, where n ‡ 3 for each anesthetic dose. The
anesthesia doses used were 175/175 and 175/200 ppm (MS-
222/isoflurane).
Determining the time to reach deep anesthesia
using 175 ppm MS-222 in combination with 175 ppm
isoflurane within different zebrafish strains
The strains used were wild type (AB), TraNac, and TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12). For
each strain, n = 5 and the statistical tests used were as
described below.
Statistical analysis
Statistical analysis between numerous groups was per-
formed by one-way analysis of variance (ANOVA) followed
by the Student-Newman-Keuls test, where p < 0.05 was
considered significant.
Results
Time to reach deep anesthesia is significantly longer
in nonpigmented TraNac fish
We have routinely noticed that ‘‘TraNac transgenic’’ fish
require longer exposure to MS-222 to reach deep anesthesia
than wild-type (AB) zebrafish. The ‘‘TraNac transgenic’’ fish
are nonpigmented, due to lacking both functional copies of the
FIG. 1. Analysis of the time to reach deep anesthesia
within different zebrafish lines using MS-222. The groups
of zebrafish tested were wild type (AB), Transgenic [Tg
(KDRmCherry:cmlc2GFP)], Casper (roy-/roy-; nacre-/
nacre-), TraNac (tra-/tra-; nacre-/nacre-), and ‘‘TraNac
Transgenic’’ [TraNac Tg (KDR:mCherry:Fabp10-rtTA:
TRE-eGFPKRASV12)]. Within each group, n = 5 and the
error bars represent the SEM. *p < 0.05 and N.S. indicates
not significant. SEM, standard error of the mean.
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genes transparent (tra) and nacre, and contain two transgenes,
KDR:mCherry and eGFPKRASV12. We therefore compared
the time to reach deep anesthesia using 168 ppmMS-222 (4.2%)
in these fish to other zebrafish genotypes to clarify and eluci-
date the phenomenon. The genotypes used for comparison in-
cluded wild type (AB), another double transgenic line [Tg
(KDRmCherry:cmlc2GFP)], and two nonpigmented zebrafish
lines, Casper and TraNac. Casper zebrafish are identical in ap-
pearance to TraNac and also share the loss of functional nacre,
however, they lack both functional copies of the gene roy.
We found that the time taken to reach deep anesthesia in
the wild-type (AB) fish was not significantly different to that
of the Tg (KDRmCherry:cmlc2GFP) or Casper lines, how-
ever, a significant increase was seen in the ‘‘TraNac trans-
genic’’ and the TraNac zebrafish (Fig. 1). Therefore, we can
determine that this was not due to the expression of fluores-
cent transgenes or the nonpigmented phenotype, but was a
result of the TraNac genotype, possibly as a result of loss of
the tra gene.
We also observed fish, of all genotypes, were responsive to
every external stimuli test performed during monitoring.
Therefore, despite the use of 168 ppmMS-222 allowing deep
anesthesia to initially be reached, it was not maintained
subsequent to placement within the FEP tube.
Extended periods of deep anesthesia can be achieved
and maintained using combined doses of MS-222
and isoflurane
Based upon a previously reported study by Huang et al.
(2010), ‘‘TraNac transgenic’’ zebrafish were anesthetized
with combined doses ofMS-222 and isoflurane, in the hope to
achieve and maintain longer periods of deep anesthesia
(Fig. 2A). In line with Huang et al. (2010), we began with
equal anesthetic concentrations as low as 50/50 ppm (MS-
222/isoflurane); however, all fish exhibited only light anes-
thesia (Table 1) after 15min of exposure (data not shown).
We next performed a dose escalation with equal amounts of
each anesthetic and found that the minimum concentration of
MS-222 and isoflurane required for 100% of fish to reach
deep anesthesia (Table 1) within 15min was 150/150 ppm
(Table 2). However, despite reaching deep anesthesia, 75%
of fish maintained in 150/150 ppm awoke within 5min of
treatment (Fig. 2A). Using a dose of 165/165 ppm resulted in
all fish staying under anesthesia, yet 60% were seen to re-
spond to external stimuli suggesting a state of light anesthesia
(Table 1). This was significantly improved when using doses
of 170/170 or 175/175 ppm, where more than 80% of fish
were maintained under deep anesthesia with no response to
external stimuli (Fig. 2A and Table 1).
To determine whether longer periods of deep anesthesia
could be achieved and maintained, we varied the amount of
isoflurane with a constant 175 ppm MS-222, as we reasoned
that MS-222 doses higher than 175 ppmwould be detrimental
to zebrafish due to a concentration of 200 ppm being rou-
tinely used as an overdose for zebrafish euthanasia.14 Our
results show that using 200 ppm of isoflurane (175/200 ppm)
had little effect on the time under deep anesthesia compared
to 175/175 ppm, while the combination of 175/250 ppm
started to trend toward a reduced time (Fig. 2B). Due to this,
FIG. 2. Analyzing time under deep anesthesia using combinations of MS-222 and isoflurane (MS-222 ppm/isoflurane
ppm) on ‘‘TraNac Transgenic’’ [TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12)] zebrafish. Equal doses of
the anesthetics (A) and variations of isoflurane concentration with 175 ppm of MS-222 (B) were analyzed. The data
presented for each group are the mean with error bars representing the SEM, where n‡ 4 for each group. Solid white bars
represent >50% of fish awakening, hatched bars represent >50% fish experiencing light anesthesia, and solid black bars
represent where at least 80% of fish remained under deep anesthesia.
Table 2. The Percentage of ‘‘TraNac Transgenic’’
[TraNac Tg (KDR:mCherry:Fabp10-rtTA:
TRE-eGFPKRASV12)] Fish to Reach
Deep Anesthesia Within 15 Min of Exposure












Within each group n ‡ 4.
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higher concentrations of isoflurane were not tested and it is
possible that the reduced time before opercula cessation was
due to toxicity. Using a regime of 175 ppm MS-222 alone
resulted in a reduced time under deep anesthesia, with a
corresponding increase in response to external stimuli as we
have previously observed for 168 ppm MS-222 (Fig. 2B).
Importantly, no significant differences in recovery time
were observed using the combined regimes described
(Fig. 2B), compared to MS-222 alone (Supplementary
Table S1; Supplementary Data are available online at www
.liebertpub.com/zeb).
Repeated use of combined MS-222 and isoflurane
consistently achieves and maintains deep anesthesia
To implement longitudinal studies, repeated anesthesia is
necessary. For CS-OPT imaging, one imaging session per
week is sufficient to see significant changes in vascular de-
velopment and remodeling.7 Based on results from Figure 2B,
we subjected groups of ‘‘TraNac transgenic’’ fish to the
combined doses of 175/175 and 175/200 ppm of isoflurane
with MS-222, once a week for 4 weeks (Fig. 3). We found that
the time under deep anesthesia varied over the 4-week study
when using a dose of 175/200 ppm of isoflurane, which was
not seen when using 175/175 ppm (Fig. 3). Therefore, we
determined that the 175/175 ppm-combined anesthetic regime
would be optimal for motionless 3D image acquisition during
longitudinal studies. Importantly, repeated exposure to these
combined doses of MS-222 and isoflurane did not impact the
health, fitness, or viability of the zebrafish. All fish experienced
rapid recoveries, did not have reduced viability, or appear
under any stress (Supplementary Table S2).
Of note, we found that individual fish that responded
slower to anesthesia or maintained opercula movement for
longer periods of time tended to exhibit this response over the
course of the study (data not shown).
Applying 175 ppm of both MS-222 and isoflurane
reduces the time to reach deep anesthesia
We tested the combined 175/175 ppm of MS-222 and
isoflurane on wild-type (AB), TraNac, and ‘‘TraNac trans-
genic’’ fish to determine whether the time to reach deep an-
esthesia compared to standard MS-222 alone in different
genetic backgrounds was affected (Fig. 4).
All fish were found to reach deep anesthesia in less than
3min. TraNac and ‘‘TraNac transgenic’’ fish have a reduc-
tion in both the time taken to reach deep anesthesia and the
variation between individual fish when using the 175/
175 ppm-combined regime compared to standard MS-222
used in Figure 1. A significant difference is still observed
FIG. 3. Time under deep anesthesia with repeated use of MS-222 and isoflurane combinations, where (A) is 175/175 and
(B) is 175/200 (MS-222 ppm/isoflurane ppm) on ‘‘TraNac Transgenic’’ [TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12)] zebrafish. Each anesthetic regime was tested over 4 weeks. The data presented for each group are the
mean with error bars representing the SEM, where n ‡ 3 for each group. The horizontal dotted line at 10min represents the
average time required for CS-OPT image acquisition. CS-OPT, compressive sensing optical projection tomography.
FIG. 4. Analysis of the time to reach deep anesthesia
within different zebrafish lines using 175 ppm of both MS-
222 and isoflurane. The groups of zebrafish tested were wild
type (AB), TraNac (tra-/tra-; nacre-/nacre-), and ‘‘TraNac
Transgenic’’ [TraNac Tg (KDR:mCherry:Fabp10-rtTA:
TRE-eGFPKRASV12)]. Within each group, n = 5 and the
error bars represent the SEM. **p < 0.01.
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between the wild-type (AB) group and the TraNac fish, in-
dicating a similar role effect as observed in Figure 1.
Discussion
In this study, we have repeatedly anesthetized our ‘‘Tra-
Nac transgenic’’ zebrafish using a combined dose of MS-222
and isoflurane to quickly reach and maintain a deep level of
anesthesia for extended periods of time. This overcomes the
shortfalls encountered when using MS-222 alone for 3D
imaging of live, nonpigmented adult zebrafish, using mo-
dalities such as CS-OPT.
It is known that with prolonged anesthesia with MS-222
alone, zebrafish are susceptible to both respiratory and car-
diac failure.14,15 It has previously been reported16 that a
combined dose of 65 ppm of both MS-222 and isoflurane in
adult wild-type zebrafish is optimal to improve the time under
deep anesthesia without impacting upon survival. Our results
show that this dose was not sufficient to induce deep anesthesia
in either wild-type zebrafish or in our ‘‘TraNac transgenic’’
fish within 15min. We did find an improvement using a
combination of both MS-222 and isoflurane, however, the
minimal dose required for deep anesthesia to be reached and
maintained was 150 ppm of both MS-222 and isoflurane.
The combination of isoflurane with MS-222 improves the
maintenance of deep anesthesia within our ‘‘TraNac trans-
genic’’ zebrafish at doses higher than 170 ppm of each an-
esthetic, which was determined through the response to an
external stimulus greater than that experienced during 3D
image acquisition. This is an important advancement for
imaging live zebrafish, whereby accurate images and quan-
tifications are dependent upon completely motionless ani-
mals during acquisition. Furthermore, there was an increase
in the time under deep anesthesia before loss of opercula
movement was observed, where the 175/175 ppm dose was
optimal. The extended time under deep anesthesia could open
up additional avenues for imaging. We have previously
achieved spatial and temporal readouts of protein activity
using Fo¨rster resonant energy transfer biosensors through
Florescence Lifetime Imaging (FLIM) OPT in zebrafish
embryos.6,17 Providing a greater period of deep anesthesia
could enable FLIM OPT in live adult zebrafish, providing
additional information in physiological and pathophysio-
logical contexts. Importantly, we have also shown that this
anesthetic regime can be repeated, and does not affect the
health or viability of the adult zebrafish. Again, a combined
dose of 175/175 ppm of each anesthetic was shown to be
optimal, where it consistently achieved an average time under
deep anesthesia of greater than 10min with little variation
throughout. This highlights its potential use for longitudinal
imaging studies.
We have also shown that both TraNac and ‘‘TraNac trans-
genic’’ fish require prolonged exposure to MS-222 to reach
deep anesthesia compared to wild-type (AB) zebrafish. This
difference is not seen in Casper or other double transgenic fish,
suggesting a role for the tra gene in regulating the MS-222
response. The mutation present in the tra gene results in a
truncated form of the mitochondrial protein mpv17, which
leads to a reduction in iridophores. It has previously been
proposed that the loss of mpv17 function could result in al-
terations in metabolism,18 so it is possible that this could ac-
count for the differences in response toMS-222. The combined
use of 175ppm of bothMS-222 and isoflurane reduces the time
to reach deep anesthesia and does not increase the recovery
period when anesthetizing the TraNac and ‘‘TraNac trans-
genic’’ fish. Therefore, the zebrafish will experience less stress
as a result. However, it is important to note a difference in time
to reach deep anesthesia is still observedwhen compared to the
wild-type (AB) fish. As a community, it is known that zebrafish
strains differ between research institutes, as do environmental
conditions, and we have shown that response to anesthesia also
differs dependent upon genetic backgrounds. Therefore, we
note that theremay be a need to perform additional adjustments
to the 175/175ppm anesthetic regime for optimization. How-
ever, based on our work in this study, it is clear that using a
combination ofMS-222 and isoflurane is superior to thewidely
used 4.2% (168 ppm) MS-222 regime.
Thus, incorporating the combined anesthetic dose of
175 ppm of both MS-222 and isoflurane can provide pro-
longed periods of deep level of anesthesia required for 3D
imaging of adult nonpigmented zebrafish, without impacting
upon recovery. Moreover, the ability to perform repeated
treatments will significantly improve the accuracy and in-
formation achievable from imaging live adult zebrafish in
longitudinal studies.
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